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Fluorescence vision using indocyanine green is a surgical tool with increasing 
applications in colorectal cancer surgery. This tool has received acceptance in sev-
eral disciplines as a potential method to improve visualization of the surgical field, 
improve lymph node resection and decrease the incidence of anastomotic leaks 
(ALs). In colorectal surgery specifically, some studies have shown that intraopera-
tive fluorescence imaging is a safe and feasible method to evaluate anastomotic 
perfusion, and its use could affect the incidence of anastomotic leaks. Currently, 
controlled trials are carried out to validate these conclusions, as well as new indica-
tions for indocyanine green such as detection and guidance in the management of 
hepatic colorectal metastases, visualization of ureters and even as tumor marking 
and improvement the lymph node harvest of early tumors. These advances could 
offer great value to surgeons and patients, by improving the accuracy and results of 
cancer resections.
Keywords: indocyanine green fluorescence, colorectal cancer surgery, anastomotic 
leaks, tumor marking, lymph node harvest
1. Introduction
Some basic concepts are necessary to define as Fluorescence, which is a form 
of luminescence, that is, it is a process of light emission, caused by an energy, in 
this case it is by ultraviolet rays and that said energy is absorbed in form of electro-
magnetic radiation to later be emitted in the form of wavelengths and thus can be 
captured by an image system.
And what is the Indocyanine green? (ICG). As it is a colorant that is soluble in 
water and has a spectral absorption of light of approximately 800 nanometers, 
this spectrum is capable of binding both oxygenated and reduced hemoglobin and 
has 5 pharmacological characteristics: one that is not metabolized by therefore it is 
considered almost inert by binding to plasma proteins. Two, which is eliminated by 
a concentration gradient, that is, passively. Three, it is eliminated by the hepatocyte 
into the bile canaliculi. Four, it does not suffer from enterohepatic circulation 
and fifth, that its use is clearly diagnostic and not curative since its approval by 
the FDA in 1960 when Fox IJ of Mayo Clinic [1], showed in a work the physical 
and metabolic properties of this substance and its use diagnosis in liver diseases, 
 ophthalmological, cardiac, neurological, etc.
Colorectal Cancer is the 4th most frequent in the USA, more than 135,000 new 
cases are diagnosed per year, of which 95,500 are colon and almost 40,000 rectal, 
with an estimated and unfortunate mortality of more than 50,000 cases, that is, 
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approximately 35% [2] . In Spain, despite the fact that a little more than 41,000 
cases per year of colorectal cancer are diagnosed according to the Spanish society 
of medical oncology (SEOM), it constitutes the first cancer in incidence in that 
country, logically due to the demographic density - incidence relationship and with 
a mortality close to 25% [3].
Another concept we must handle is anastomotic leakage because as we all know 
the standard care in colon and rectal cancer to date is surgery, before or after neo-
adjuvant treatment. And what is an anastomotic leak?. Since a very simple concept 
is the one proposed in 1991 by the study group of surgical infections in the United 
Kingdom [4], where it comments that “it is the escape of luminal content from the 
surgical union between two hollow viscera”. Concept that seems very simple, but 
that generates a lot of controversy at least in the literature where they talk about the 
subject, because these works are not homogeneous many times at least in the diag-
nosis of this entity since there may be an anastomotic leak, for example radiologi-
cal, It is that detected in imaging studies performed routinely, without the patient 
showing signs or clinical symptoms, but does not require changes in management. 
To give an example, it is the typical case of the patient who has been left with 
an ileostomy or protective colostomy and before closing or restoring it, imaging 
studies are performed and a leak is detected or the patient who is performed due to 
postoperative leak prevention protocols blood markers such as C-reactive protein, 
procalcitonin or other acute phase reactants that, despite the patient being asymp-
tomatic, can lead to imaging studies. It can also be an anastomotic leak with a minor 
clinic where the patient presents intestinal or purulent discharge from the wound 
or drainage, associated with fever, leukocytes, presence of abscess. And they do not 
require surgical intervention at least initially, but lengthens the hospital stay, the 
use of antibiotics, the need for percutaneous drainage, endoscopic procedures, etc. 
And the anastomotic leak that already presents with greater symptoms, that is, with 
more spectacular symptoms due to a degree of severe disruption of the anastomosis 
and that does require surgical intervention.
And how frequent is an anastomotic leak in colorectal surgery? This will depend 
on the anastomosed segment. And according to this multicenter and prospective 
study carried out in Europe [5], the leak rate of an ileocolic anastomosis varies 
between 1 to 18%, of the colo-colonic between 2 to 13%, ileo-rectal between 3 to 11% 
and colorectal or coloanal between 5 to 21%, although on average the Spanish Rectal 
Cancer Project carried out in the main colorectal surgery units in Europe showed an 
average leakage rate for rectal anastomosis of 10% [6]. And well, the anastomotic 
leak is associated with a large increase in morbidity and mortality, therefore it is the 
most feared complication by every surgeon and any health system in the world due 
to expenses that generates that are calculated that they are approximately between 
1.6 to 5 million Euros per year or 40,000 € approximately per patient [7].
And what are the risk factors for an anastomotic leak to occur? They are 
 preoperative risk factors that generally depend on the patient and that are many but 
the most important seem to be obesity, age, sex, tobacco, alcohol, steroids, non-
steroidal anti-inflammatory drugs, nutritional status, type of ASA, tumor size, the 
performance of chemo or radiotherapy previously and intraoperative factors that 
depend a lot on the surgeon and that perhaps are the ones that we can intervene 
or modify with some exceptions such as the distance from the anal margin, since 
the closer the greater the risk, but if we could modify, for example, the duration of 
the intervention, perioperative sepsis or need for transfusion, the performance of 
protective stomas that are known not to reduce the incidence of anastomotic leaks, 
but if the severity of their presence, the intestinal preparation that some studies say 
that there are no differences with their use, but others who speak that if especially 
when using them with antibiotics and especially orally, this for a reason perhaps 
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from the gut microbiota. And another very important factor is the quality of the 
anastomosis that we perform, because as we all know it must be tension-free and 
adequately vascularized, regardless of whether it is handsewn or mechanical. In 
addition to predicting the risk of anastomotic leak, there are many scales in the 
literature, some that predict morbidity and mortality and indirectly the risk of 
leak, such as the ASA, APACHE, POSSUM and others more specific such as the 
Dekker Score or Colorectal Leak Score (CLS) [8], which is perhaps the most used 
that it consists of 11 items that score the patient between 0 and 41, with a high risk 
of AL being a score greater than 11; this with a sensitivity of 67% and Specificity 
of 89%; However, on the internet, very practical and easy scales and calculators 
are  available, such as the www.anastomoticleak.com [9] and the real-score that is 
specific for rectal cancer [10].
Now, how do we evaluate intraoperatively that our anastomosis is fine and that 
it will not leak? Well, there is a subjective assessment such as the visualization of 
the anastomosis, with the fingers we evaluate the caliber, the color of the serosa and 
the mucosa, which bleeds when cutting the intestine, palpating the pulses of the 
Riolano arch, etc. But unfortunately demonstrated by many works and corrobo-
rated by Karliczek in 2009 [11], the prediction of AL with these methods is very 
low and he recommends in his work to carry out some other tests to make a more 
objective assessment and here they enter by for example, the verification of donuts 
when we use mechanical suture, air leak test or with methylene blue as sometimes 
used by some bariatric surgeons and or the performance of intraoperative endos-
copy. Regarding air leakage, in a systematic review and meta-analysis published 
in 2016 by a Chinese group [12], they showed that ALs are lower in patients who 
undergo the test vs. those who do not, but that it is not statistically significant and 
that when the air test is positive that this occurred according to the review of the 
multiple works on the subject between 1.5 to 24.7%, the AL is higher 11.4% vs. 4.2% 
in those that is negative. And this is the reason why it continues to be used because 
in the cases that are positive, some measure must be taken, be it reinforcement of 
the anastomosis, performance of protective ostomies or replacement thereof.
The performance of intraoperative endoscopy, this allows us to evaluate the air 
leak, the staple line, presence of bleeding or areas of ischemia. In fact, there is a 
classification in degrees proposed by Alessio Pigazzi et al. [13] of the University of 
Irving, California. Grade I is an anastomosis with the pink mucosa, well perfused 
through the entire staple line. Grade II there is ischemia or congestion in less than 
30% on one side of the anastomosis and Grade III there is ischemia or congestion in 
more than 30% on one side of the anastomosis or any degree on both sides. In this 
work with 110 patients with rectal anastomosis who underwent endoscopic evalua-
tion, 96 being Grade I, that is, normal, 10 were Grade II and 4 patients were Grade 
IIII. Of these 4, all were taken to Grade I, that is, the anastomosis was redone. And 
the percentage of leakage was 9.78% for the normal ones, that is grade I, that is 9 
patients out of 96. Of 40% in Grade II, that is 4 patients out of 10 and 0% in grades 
III that they took to GI. What this study showed despite being with few patients is 
that Grade III patients have to have the anastomosis re-done, Grade II have a very 
high risk of AL, so some other measure would have to be taken and Grade I despite 
being normal they escape up to almost 10%; therefore, is it possible to have another 
method that reduces this risk of AL?
And the answer seems to be yes, and already in 2010, 50 years after the FDA 
approval of Indocyanine Green, a German group made the first publication on the 
use of green to prevent anastomotic leaks in colorectal surgery. In this work they 
included 402 patients divided into two groups. A group who underwent perfusion 
of the anastomosis with green between 2005 and 2008 and whose leak rate was 3.5% 
and a retrospective group between 1998 and 2003 who did not evaluate perfusion 
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with green and whose rate of AL was 7.5%, that is, 4% more than the group with 
green. This work carried out by the disciples of Dr. Christian Tons was a dedication 
for him who died in 2008 before its publication, this because he is considered the 
pioneer of the use of this technology in colorectal surgery and inventor of the first 
system for this, the IC View® from Pulsion Medical Systems [14].
In these almost 10 years, interesting scientific publications on the subject 
have begun to appear and also private companies have improved the technology, 
for example a Canadian commercial company called Novadaq® appears, which 
is leading, already financed and supported several works in this regard with its 
system called PINPOINT ™ for laparoscopic surgery or the SPY Elite ™ for open 
surgery [15]. In fact, this company began to be part of Stryker in 2017. And thus also 
intuitive since 2016 its latest generation Da Vinci Robot Xi, the Firefly system™ for 
fluorescence use [16]. Companies like Medtronic®, Storz® among others have also 
entered the market with this technology.
2. Evolution of ICG in colorectal cancer and literature experience
The first prospective, multicenter study with the use of ICG in prospective 
colorectal surgery was called Pillar II published in 2015 [17]. Here the utility and 
feasibility of the use of indocyanine green in left colectomy and anterior laparoscopic 
rectal resections were evaluated using the PINPOINT™ technology from Novadaq®. 
Among 11 hospitals in the USA, 139 patients were included, 44% operated for diver-
ticulitis, 25% for rectal cancer and 21% for colon cancer. The feasibility of using green 
was 99% with 1.4% AL and the interesting thing about the work is that the use of this 
technology allowed 11 patients, that is, 8% to change the area where the colon was cut 
due to poor perfusion in the site previously chosen by the surgeon before the place-
ment of green, and specify that of these 11 patients when doing this, none had AL.
In 2017, the first systematic summary and metanalysis with what was published 
up to that date on the use of green to prevent AL in colorectal surgery was published 
by Espin et al. [18] in this publication after the exclusion of many methodologically 
weak studies, they include 5 non-randomized studies with 1302 patients of which 
555 were operated using ICG and 747 without ICG. The overall rate of AL in this 
review was 7.4%, demonstrating that ICG reduces the risk of AL in colorectal cancer 
with a p = 0.06. And specifically, it was seen that in rectal cancer the leak rate in the 
group with ICG was 1.1% vs. 6.1% in the group without ICG. This with a p = 0.02. 
But it also shows that when analyzing the use of green in both malignant and benign 
diseases, there are no significant differences in the prevention of leakage with its 
use. The authors in this review conclude that the literature up to that point is very 
heterogeneous and that new randomized, randomized and multicenter studies 
should be carried out for what they propose the ICEBerg Trial [19], a study carried 
out to evaluate the use of ICG vs. not in colorectal surgery.
Morales Conde et al. published in 2019 a prospective, monocentric study [20], 
that included 192 patients who were divided into 4 groups. Group A consisted of 67 
patients undergoing right hemicolectomy, group B 9 patients undergoing segmental 
resection of the splenic angle, Group C with 81 patients undergoing left hemicolec-
tomy, and group D with 35 patients undergoing anterior rectal resection. There was 
a change in the area of  colon section in 35 patients, that is, 18.2%, and these were 
distributed in 4 (6%) of Group A of right hemicolectomy 1 (11%) of group B of 
segmental resection of the splenic angle, 21 (25.9%) from group C for left hemico-
lectomy and 9 (25.7%) from group D for anterior resection. The leak rate was 2.6% 
(5 patients), but none of the AL have been those that were able to change the cut site 
with the evaluation of the ICG.
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In January 2019, another systematic review and meta-analysis on anastomotic 
tests in colorectal surgery in the new millennium was published that included a 
total of 11 articles with 3844 patients and where direct analyzes were compared 
between the control group, that is, the one that was not did no intraoperative leak 
test (No IOLT) with which it was verified with ICG or with ALT (Air Leak Test) 
and with IOC (Intraoperative Colonoscopy). This meta-analysis concluded that 
AL are higher in the No IOLT group, that is, no test compared to green with a 
p = 0.0004 and also that they are higher when compared with ALT (Air Leak Test) 
and IOC (Intraoperative Colonoscopy), but these data were not statistically signifi-
cant [21]. In September Wexner et al. [22] recommend the quadruple evaluation 
of colorectal anastomoses to achieve the greatest possible safety, doing it in the 
following way: First ICG to decide the level of the proximal colon cut, second air 
test to the rectal stump, that is, before doing the anastomosis, third confirmation 
of the donuts from the self-suturing machine when performing the anastomosis 
and fourth the intraoperative colonoscopy with white light and again with green to 
evaluate the perfusion of the mucosa. In this reading it is recommended that what 
should never be lacking is the green test, but that one test does not discriminate 
against another.
In 2020 the FLAG randomized trial [23], with 377 cases, 187 had ICG and 190 
were in the non-ICG group and they demonstrated ICG did not decrease the rate of 
AL of high anastomoses (9–15 cm from the anal verge), at 1.3% vs. 4.6% in the non-
ICG group (P = 0.37). In contrast, a decrease in AL rate was found for low (4–8 cm) 
colorectal anastomoses (14.4% in ICG vs. 25.7% in the non-ICG   group; P = 0.04).
Currently, some large randomized studies are being carried out such as the 
PILLAR III [24] and two more which are in the recruitment phase [25, 26], that is 
expected to have soon any results about this. And on the other hand, they are trying 
to investigate and elucidate a question that many colorectal surgeons ask them-
selves. How green should green be? so that we can say that the evaluated tissue is 
well perfused. And this question is the one that many of the detractors of this tech-
nique ask themselves that perhaps creates uncertainty when they face a real-time 
image with green. And for this the experts in conjunction with the companies are 
trying to find a solution and for that at least Medtronic® with its new technology 
called Elevisión® [27], have included a system for quantifying green in percent-
ages, where through colors and on a percentage scale that it goes from 0 to 250% we 
can quantitatively know the irrigation of each area of the colon (Figure 1). And this 
has already been working and published by plastic surgeons. They have shown when 
performing a skin flap, that when an area of the flap has more than 33% of the most 
perfused point, it can be ensured that 88% of cases that area will not be necrotic. 
And when that value is less than 25% in 90% of the cases it will be necrotic [28, 29]. 
This is being tried to evaluate and agree, that is, what percentage of perfusion we 
should have in the colon to decide that it is well vascularized.
Now indocyanine green only serves to assess anastomotic perfusion? And well, 
although perhaps if it is its most important function, it may have others like the 
ones we show in a video published by Vargas et al. [30], in the Spanish journal of 
surgery of a clinical case of upper rectum cancer where we use green not only for 
the evaluation of the anastomotic perfusion but also for marking the tumor and 
as a guide at the time of lymphadenectomy, these very important points to achieve 
an ideal oncological or radical surgery. The important difference with the little-
published marking is that we have done the marking by rectoscopy 4 hours before 
surgery (Figure 2), diluting the green ampoule in 100 cc of serum and from there 
we have injected 0.3 cc to 2 cm at the submucosal level distal to the tumor in order 
to locate the lesion intraoperatively because it is very small (only 3 cm) and to mark 
the lymph nodes to be resected as a kind of sentinel lymph node (Figure 3). What is 
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published in the literature in this regard are still clinical cases or videos, but there 
is some experience in the literature regarding lymphadenectomy, especially in right 
colon tumors with the intention of performing surgery with D3 lymphadenectomy 
or complete excision of the mesocolon as shown by the work on a clinical case of 
Complete excision of the mesocolon in a right hemicolectomy using the Firefly 
fluorescence system of the Da Vinci® robot [31]. Now the injection of green in 
published cases is performed intraoperative technique of subserosal ICG injection 
with a fine needle for sentinel lymph node (SLN) [16]. This technique is feasible in 
very large tumors that can be located without problems via laparoscopy or robotics 
or that have been previously marked in a conventional way with ink (an important 
difference with our technique). The studies published to date do not show any 
statistically significant difference in the number of lymph nodes dissected using 
marked-oriented lymphadenectomy in advanced tumors but in early colon tumors, 
that is, T1 or T2. These findings have been demonstrated by Asian groups that 
have the most experience in this, as shown in a work published in 2015 but using 
Figure 1. 
Quantification of the vascularization of the colon.
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Figure 3. 
Lymph node marking with ICG for lymphadenectomy.
Figure 2. 
Location of the tumor marked prior to surgery with ICG.
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conventional ink marking [32] and this other by, which is the only one published to 
date, used indocyanine green as a marker of the tumor [33]. In middle-low rectal 
cancer local recurrence greatly affects the treatment efficiency and the survival 
outcomes for patients with rectal cancer. Lateral pelvic lymph node (LPLN) metas-
tasis (LPNM) is an important factor for local recurrence after surgery in patients 
with middle-low rectal cancer, and approximately 8.6% to 21.0% of patients with 
rectal cancer have associated LPNM. As one of the effective treatment methods, 
laparoscopic LPLN dissection (LPND) can significantly reduce the local recurrence 
rate compared with simple total mesorectal excision (TME) surgery. In clinical 
applications, LPND is limited by various complications because the ureters and 
hypogastric nerves might be damaged without efficient guidance, and for this using 
ICG improve the dissection increasing the numbers of lymph nodes harvested and 
decreasing complications [34].
There are also publications of its use in various situations, such as in the Japanese 
article of August 2019 by et al. [35] where this group devised a Kit that they called 
IRIS U Kit that allows them to transilluminate the urethra and prostate in transanal 
total mesorectal excision (TaTME) with the intention of avoiding one of the most 
feared complications of this technique, which is the injury of the urinary tract. As 
well as this, there are already published cases of its use, for example, in the transil-
lumination of the ureters in very difficult cases from the surgical point of view, such 
as big tumors, complicated diverticulitis or pelvic surgery [36]. In 2017, a Belgian 
Group published a systematic review [37] of the use of green as a guide in the diag-
nosis and surgical treatment of hepatic or peritoneal metastases of colorectal origin. 
This work concluded that the use of green facilitates the detection and resection of 
hepatic and peritoneal metastases of colorectal origin.
3. Conclusions
Anastomotic leaks after colorectal surgery continue to be a serious public health 
problem; therefore the use of new therapies could minimize this problem.
With regard to standard tests for the prevention of ALs, they continue to be 
used for the structural evaluation of the anastomosis, but with the knowledge that 
their efficacy is often insufficient; for this reason the use of fluorescence allows us 
to evaluate anastomotic perfusion is becoming more and more important every day 
and gives us greater surgical safety for the benefit of the patient.
In addition, we must remember that the ICG is not only limited to the anasto-
motic perfusion, new functions begin to emerge, such as its use in tumor marking, 
lymphadenectomy, location of ureters, urethra, liver and peritoneal metastases, 
among other functions.
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SEOM Spanish Society of Medical Oncology
FDA  Food Drug Administration
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CLS  Colorectal Leak Score
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TME Total mesorectal excision
TaTME Transanal total mesorectal excision
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